⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15846758 | 0.92 | KMT2A (0.41) | — | |
| SCHEMBL28193263 | 0.90 | TSHR (0.44) | — | |
| SCHEMBL7948617 | 0.90 | TSHR (0.44) | — | |
| SCHEMBL5685729 | 0.90 | TSHR (0.44) | — | |
| SCHEMBL290688 | 0.86 | — | — | |
| SCHEMBL2360898 | 0.84 | ACHE (0.42) | — | |
| SCHEMBL2369749 | 0.84 | — | — | |
| SCHEMBL4552804 | 0.82 | TRPA1 (0.50) | — | |
| SCHEMBL1986858 | 0.82 | SMN1; SMN2 (0.43) | — | |
| SCHEMBL11517580 | 0.80 | ALDH1A1 (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 66 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230054591-A1 | AGROCHEMICAL GEL COMPOSITIONS | MONSANTO TECHNOLOGY LLC | 2023-02-23 | — | — | US | claimed |
| EP-2427172-B1 | A METHOD FOR TREATING OVERACTIVE BLADDERS AND A DEVICE FOR STORAGE AND ADMINISTRATION OF TOPICAL OXYBUTYNIN COMPOSITIONS | ALLERGAN SALES LLC (US) | 2017-11-01 | — | — | EP | claimed |
| EP-1565136-B1 | COMPOSITIONS FOR TRANSDERMAL OXYBUTYNIN THERAPY | WATSON PHARMACEUTICALS INC (US) | 2015-02-25 | — | — | EP | claimed |
| EP-2612629-A1 | Compositions for transdermal oxybutynin therapy | Watson Pharmaceuticals, Inc. (US) | 2013-07-10 | — | — | EP | claimed |
| EP-2544532-A2 | AGROCHEMICAL GEL COMPOSITIONS | Monsanto Technology LLC (US) | 2013-01-16 | — | — | EP | claimed |
| US-8241662-B2 | Unoccluded topical oxybutynin gel composition and methods for transdermal oxybutynin therapy | WATSON LABORATORIES, INC. (US) | 2012-08-14 | — | — | US | claimed |
| WO-2011113061-A2 | AGROCHEMICAL GEL COMPOSITIONS | MONSANTO TECHNOLOGY LLC (US) | 2011-09-15 | — | — | WO | claimed |
| US-11707451-B2 | Pharmaceutical composition for modified release | ASTELLAS PHARMA INC. (JP) | 2023-07-25 | — | — | US | disclosed |
| US-20230054591-A1 | AGROCHEMICAL GEL COMPOSITIONS | MONSANTO TECHNOLOGY LLC | 2023-02-23 | — | — | US | disclosed |
| US-20220280418-A1 | ORAL PHARMACEUTICAL COMPOSITION | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 2022-09-08 | — | — | US | disclosed |
| EP-4015001-A1 | ORAL PHARMACEUTICAL COMPOSITION | Otsuka Pharmaceutical Co., Ltd. (JP) | 2022-06-22 | — | — | EP | disclosed |
| EP-4015002-A1 | ORAL PHARMACEUTICAL COMPOSITION CONTAINING HETEROCYCLIC COMPOUND | Otsuka Pharmaceutical Co., Ltd. (JP) | 2022-06-22 | — | — | EP | disclosed |
| CN-114286722-A | Catalyst comprising coke and process for producing dienes | 维尔萨利斯股份公司 | 2022-04-05 | — | — | CN | disclosed |
| US-20070148195-A1 | Compositions and methods for transdermal oxybutynin therapy | ALLERGAN SALES, LLC | 2007-06-28 | — | — | US | disclosed |
| US-7179483-B2 | Compositions and methods for transdermal oxybutynin therapy | WATSON PHARMACEUTICALS, INC. (US) | 2007-02-20 | — | — | US | disclosed |
| US-7029694-B2 | Compositions and methods for transdermal oxybutynin therapy | WATSON LABORATORIES, INC. (US) | 2006-04-18 | — | — | US | disclosed |
| US-20050226898-A1 | Compositions and methods for transdermal oxybutynin therapy | WATSON PHARMACEUTICALS, INC. | 2005-10-13 | — | — | US | disclosed |
| EP-1565136-A2 | COMPOSITIONS AND METHODS FOR TRANSDERMAL OXYBUTYNIN THERAPY | Watson Pharmaceuticals, Inc. (US) | 2005-08-24 | — | — | EP | disclosed |
| WO-2004041188-A2 | COMPOSITIONS AND METHODS FOR TRANSDERMAL OXYBUTYNIN THERAPY | WATSON PHARMACEUTICALS, INC. (US) | 2004-05-21 | — | — | WO | disclosed |
| US-20030147926-A1 | Compositions and methods for transdermal oxybutynin therapy | WATSON PHARMACEUTICALS, INC. | 2003-08-07 | — | — | US | disclosed |